CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 351,388	$ 388,171
TOTAL ASSETS	351,388	388,171
CURRENT LIABILITIES:
Accounts payable and accrued expenses	3,473	4,985
TOTAL CURRENT LIABILITIES	3,473	4,985
STOCKHOLDERS' EQUITY:
Preferred stock, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible preferred stock; 50,000 shares designated; no shares issued and outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, $0.00001 par value; 200,000,000 shares authorized; 62,379,759 shares issued and 61,882,172 shares outstanding at March 31, 2024 and December 31, 2023	619	619
Treasury stock, $0.00001 par value 497,587 shares at March 31, 2024 and December 31, 2023	(49,759)	(49,759)
Additional paid-in capital	8,839,367	8,839,367
Accumulated deficit	(8,442,312)	(8,407,041)
TOTAL STOCKHOLDERS' EQUITY	347,915	383,186
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 351,388	$ 388,171